0001209191-13-053098.txt : 20131119
0001209191-13-053098.hdr.sgml : 20131119
20131119162831
ACCESSION NUMBER: 0001209191-13-053098
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131025
FILED AS OF DATE: 20131119
DATE AS OF CHANGE: 20131119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mack David Henry
CENTRAL INDEX KEY: 0001341642
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 131230291
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2013-10-25
2013-10-25
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001341642
Mack David Henry
ONE EMBARCADERO CENTER, 37TH FLOOR
SAN FRANCISCO
CA
94111
1
0
0
0
Option (right to buy)
3.15
2023-09-12
Common Stock
28000
D
This option was granted on September 12, 2013. The option is exercisable as follows: on or after the 12th day of each successive month beginning October 12, 2013, the option may be exercised to purchase up to an additional 1/36th of the number of option shares.
Reflects a one-for-five reverse stock split of the Issuer's common stock effected October 8, 2013.
David Mack
2013-11-19